President Donald Trump signed an executive order yesterday regarding government regulations that may have ramifications for the recently passed 21st Century Cures Act, Stat News reports.
The order states that for every new regulation, at least two must be eliminated, according to the Washington Post. The Post notes that rescinding regulations leads to a process that involves drafting rules, rewriting regulations, and comment periods and can spur litigation. At the very least, it adds, the order will add a time-consuming element to proposing any new congressional legislation or agency regulation.
And that, Stat News says, could affect the 21st Century Cures Act. The Cures Act, which was passed in December, not only provides $4.8 billion over 10 years to National Institutes of Health programs, but also $500 million to the Food and Drug Administration, while also changing some of the agency's drug and medical device approval policies. In particular, the law instructs the FDA to come up with new pathways to approve medical device and evaluate biomarkers and other drug development tools, all to speed up the drug approval process, Stat News adds.